<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02331563</url>
  </required_header>
  <id_info>
    <org_study_id>20.10.2014/24/07</org_study_id>
    <nct_id>NCT02331563</nct_id>
  </id_info>
  <brief_title>Adjuvant Effect of Dexmedetomidine in Ultrasound (USG) Guided Transvers Abdominis Plane Block</brief_title>
  <acronym>USG</acronym>
  <official_title>Adjuvant Effect of Dexmedetomidine for the Ultrasound Guided Transversus Abdominis Plane Block in Patients Undergoing Laparascopic Cholecystectomy: a Randomized Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kırıkkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kırıkkale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A total of 60 adult patients American Society of Anesthesiologists physical status I,II, III
      were randomized to Group B (n = 30) receiving TAP block with 0.25% bupivacaine and Group D (n
      = 30) with 0.5 mcg/kg dexmedetomidine added to 0.25 % bupicavaine followed by general
      anaesthesia. Total local anaesthetic volume was standardised with 20 ml each sides of the
      abdomen. Hemodynamic responses to surgical incision and intraoperative fentanyl consumption
      were noted. Visual analog scale (VAS) scores were assessed on the emergence, at 1, 2, 3, 4,
      5, 6 and 24 h. Time to first rescue analgesic (when VAS ≥4 cm or on demand), duration of
      postoperative analgesia, incidence of postoperative nausea-vomiting were also noted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transversus abdominis plane (TAP) block has been shown to provide postoperative pain relief
      following various abdominal and inguinal surgeries. The aim of this randomised controlled
      trial was to assess the effect of transversus abdominis plane (TAP) blocks on opioid
      requirements and median hospitai stay, postoperative nause and vomitting in patients
      undergoing laparoscopic cholecystectomy.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    patients should have assurance to attend this study, money is the main problem
  </why_stopped>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>opioid requirement</measure>
    <time_frame>24 hr</time_frame>
    <description>postoperative relief</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative nause and vomiting</measure>
    <time_frame>24 hrs</time_frame>
    <description>patient relief</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>0.5% bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group 1 receiving TAP block with 0.25% bupivacaine 20 ml for each side of abdomen Bupivacaine is a local anaesthetic agent. transvers abdominis plane block with %0.5 Bustesin which is diluated with normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine added bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group II receiving TAP block with 0.25% bupivacaine + 0.5 mcg/kg dexmedetomidine each side of abdomen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>ultrasound guided transvers abdominis plane block</description>
    <arm_group_label>dexmedetomidine added bupivacaine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25 % bupivacaine</intervention_name>
    <description>ultrasound guided transvers abdominis plane block</description>
    <arm_group_label>0.5% bupivacaine</arm_group_label>
    <other_name>0.5% Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients undergoing laparascopic cholecystectomy

        Exclusion Criteria:

          -  Story of allergy to bupivacaine and dexmedetomidine

          -  The surgery preceeded to laparatomy

          -  Recent abdominal operation history
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferda Yaman, assist prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kırıkkale University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kırıkkale University School of Medicine Department of Anaesthesiology and Reanimation</name>
      <address>
        <city>Kırıkkale</city>
        <state>Yahşihan</state>
        <zip>71451</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2015</study_first_submitted>
  <study_first_submitted_qc>January 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2015</study_first_posted>
  <last_update_submitted>September 3, 2015</last_update_submitted>
  <last_update_submitted_qc>September 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kırıkkale University</investigator_affiliation>
    <investigator_full_name>Ferda Yaman</investigator_full_name>
    <investigator_title>assist prof dr</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

